本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Xeris制药

5.44
+0.33006.46%
盘前5.440.00000.00%08:01 EDT
成交量:375.97万
成交额:2,029.65万
市值:8.71亿
市盈率:-18.07
高:5.49
开:5.08
低:5.00
收:5.11
数据加载中...
2021/07/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/19

重要事件披露

8-K - Current report
2021/07/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/08

重要事件披露

8-K - Current report
2021/05/25

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/24

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/24

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/24

重要事件披露

8-K - Current report
2021/05/24

企业合并公告

425 - Prospectuses and communications, business combinations
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/06

重要事件披露

8-K - Current report
2021/03/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/11

重要事件披露

8-K - Current report
2021/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/09

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/09

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals